Literature DB >> 28935367

From Symptom to Diagnosis-The Prediagnostic Symptomatic Interval of Pediatric Central Nervous System Tumors in Austria.

Amedeo A Azizi1, Kirsten Heßler2, Ulrike Leiss2, Chryssa Grylli2, Monika Chocholous2, Andreas Peyrl2, Johannes Gojo2, Irene Slavc2.   

Abstract

BACKGROUND: Children with central nervous system (CNS) tumours may present with a multitude of symptoms, ranging from elevated intracranial pressure to focal neurological deficit. In everyday practice, some signs may be misleading, thereby causing prolonged prediagnostic symptomatic intervals. Prediagnostic symptomatic intervals are longer for pediatric brain tumors than for other childhood malignancies. This study evaluated prediagnostic symptomatic intervals and parental and diagnostic intervals for pediatric patients with CNS tumours in Austria. It also considered socioeconomic factors.
METHODS: Patients ≤ 19 years of age treated at the Medical University of Vienna and diagnosed during the years 2008 to 2013 were included. Patients diagnosed incidentally or by screening were excluded.
RESULTS: Two hundred twelve consecutive patients were included in the study. They reflected the expected spectrum of CNS tumors. Patients presented with a median of five symptoms at diagnosis, most frequently with signs of elevated intracranial pressure. The median prediagnostic symptomatic interval was 60 days (0 days to seven years), the median parental interval was 30 days (0 days to 6.7 years), and the median diagnostic interval was three days (0 days to 6.5 years). In spinal tumors alone (n = 7), the median prediagnostic symptomatic interval was 70 days (ten days to seven years), and three of seven patients had a prediagnostic symptomatic interval longer than 320 days. Young age, higher tumor grade, and ataxia were associated with a shorter prediagnostic symptomatic interval. Localization in the supratentorial midline, histology of craniopharyngioma, and endocrine symptoms prolonged the prediagnostic symptomatic interval. There was a clear trend for longer prediagnostic symptomatic interval in non-native speakers.
CONCLUSIONS: Results are comparable to other industrialized countries. However, long delays in diagnosis of central nervous system tumors still occur, urging increased awareness.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  brain tumor; central nervous system tumor; children; latency; presymptomatic interval; spinal tumor

Mesh:

Year:  2017        PMID: 28935367     DOI: 10.1016/j.pediatrneurol.2017.08.006

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  7 in total

1.  Patterns, treatments, and outcomes of pediatric central nervous system tumors in Sudan: a single institution experience.

Authors:  M Mohammed Ali Elhassan; A Abdalla Mohamedani; H Hussein Mohammed Osman; N Osman Yousif; N Mohamed Elhaj; I Qaddoumi
Journal:  Childs Nerv Syst       Date:  2019-01-04       Impact factor: 1.475

2.  Factors associated with delayed diagnosis among Filipino pediatric brain tumor patients: a retrospective review.

Authors:  Patricia C Orduña; Cheryl Anne P Lubaton-Sacro
Journal:  CNS Oncol       Date:  2022-06-09

3.  The Role of Time as a Prognostic Factor in Pediatric Brain Tumors: a Multivariate Survival Analysis.

Authors:  Eduardo Javier Barragán-Pérez; Carlos Enrique Altamirano-Vergara; Daniel Eduardo Alvarez-Amado; Juan Carlos García-Beristain; Fernando Chico-Ponce-de-León; Vicente González-Carranza; Luis Juárez-Villegas; Chiharu Murata
Journal:  Pathol Oncol Res       Date:  2020-07-13       Impact factor: 2.874

4.  Clinical presentation of young people (10-24 years old) with brain tumors: results from the international MOBI-Kids study.

Authors:  Angela Zumel-Marne; Michael Kundi; Gemma Castaño-Vinyals; Juan Alguacil; Eleni Th Petridou; Marios K Georgakis; Maria Morales-Suárez-Varela; Siegal Sadetzki; Sara Piro; Rajini Nagrani; Graziella Filippini; Hans-Peter Hutter; Rajesh Dikshit; Adelheid Woehrer; Milena Maule; Tobias Weinmann; Daniel Krewski; Andrea T Mannetje; Franco Momoli; Brigitte Lacour; Stefano Mattioli; John J Spinelli; Paul Ritvo; Thomas Remen; Noriko Kojimahara; Amanda Eng; Angela Thurston; Hyungryul Lim; Mina Ha; Naohito Yamaguchi; Charmaine Mohipp; Evdoxia Bouka; Chelsea Eastman; Roel Vermeulen; Hans Kromhout; Elisabeth Cardis
Journal:  J Neurooncol       Date:  2020-03-03       Impact factor: 4.130

Review 5.  Managing children with brain tumors during the COVID-19 era: Don't stop the care!

Authors:  Michele Antonio Capozza; Silvia Triarico; Giorgio Attinà; Alberto Romano; Stefano Mastrangelo; Palma Maurizi; Paolo Frassanito; Federico Bianchi; Tommaso Verdolotti; Marco Gessi; Mario Balducci; Luca Massimi; Gianpiero Tamburrini; Antonio Ruggiero
Journal:  Comput Struct Biotechnol J       Date:  2021-01-12       Impact factor: 7.271

6.  Atypical teratoid rhabdoid tumor in the cerebellum of a 7-year-old boy presenting with headache after a fall.

Authors:  Leena Iqbal; Philip S Nawrocki; Christine Radivoj
Journal:  J Am Coll Emerg Physicians Open       Date:  2021-01-14

7.  Presenting symptoms and time to diagnosis for Pediatric Central Nervous System Tumors in Qatar: a report from Pediatric Neuro-Oncology Service in Qatar.

Authors:  Ata U R Maaz; Tayseer Yousif; Ayman Saleh; Ian Pople; Khalid Al-Kharazi; Jehan Al-Rayahi; Naser Elkum; Muzaffar Malik
Journal:  Childs Nerv Syst       Date:  2020-07-24       Impact factor: 1.475

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.